AKTX | Akari Therapeutics
Quick infos Headquarters: United Kingdom Trade prices Volume: Market Cap: 59.34M Prev closed: 2.16 Open: 2.05 High: 2.1 Low: 1.86 52 week low: 1.56 52 week high: 9.2 Dividends: No Dividends Next ER: April 11, 2023 Before Market Opens
Company Profile Akari Therapeutics develop life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.
Earnings History Date EPS / Forecast Revenue / Forecast September 27, 2023 June 1, 2023 March 22, 2023 - / - - / - November 17, 2022 -0.02 / -0.04- / -September 29, 2022 - / - - / - view more
Historical Data Date Price Open High Low Vol Change ER Jul 5, 2022 0.9500 0.9500 0.9500
0.8000
23.95K 1.06% Jul 1, 2022 0.9400 0.9999 0.9999
0.9100
104.29K -5.99% Jun 30, 2022 0.9999 1.0100 1.0100
0.9500
11.32K 5.25% Jun 29, 2022 0.9500 0.9200 1.0200
0.9200
88.92K -0.52% Jun 28, 2022 0.9550 0.9500 0.9900
0.9000
56.86K -2.55% Jun 27, 2022 0.9800 0.9500 1.0200
0.9400
67.30K -1.01% Jun 24, 2022 0.9900 0.9900 1.0200
0.9800
24.19K 0.51% Jun 23, 2022 0.9850 0.9700 1.0300
0.9500
87.92K 1.55% Jun 22, 2022 0.9700 0.9700 1.0100
0.9550
57.50K -1.02% Jun 21, 2022 0.9800 0.9600 1.0100
0.9600
24.30K -2.97% view more
NASDAQ - Nasdaq Stock Market
News
Akari Therapeutics receives Nasdaq notice on minimum bid price rule seekingalpha.com Oct 29, 2022 4:54 am Akari Therapeutics GAAP EPS of $0.00 seekingalpha.com Sep 27, 2022 9:00 pm Akari Therapeutics announces $12.75M registered direct offering seekingalpha.com Sep 12, 2022 9:00 pm
Akari Therapeutics to Present Its Phase III Plans at the International Pemphigus & Pemphigoid Foundation (IPPF) Patient Education Conference finance.yahoo.com Sep 29, 2020 9:30 am
Microcap Biotech Akari Rallies On Coversin Trial Results finance.yahoo.com Sep 3, 2020 11:04 am
Akari's 2-Day Rally: What You Need To Know finance.yahoo.com Sep 3, 2020 10:54 am Akari Therapeutics' stock rockets on heavy volume after FDA grants nomacopan 'Fast Track' designation marketwatch.com Sep 3, 2020 8:58 am Akari hits over five-month high on reprioritization of pipeline seekingalpha.com Aug 2, 2022 1:51 am Akari Therapeutics announces positive results from pre-clinical studies of eye disease treatment seekingalpha.com Jul 28, 2022 10:06 pm Akari Therapeutics GAAP EPS of $0.00 seekingalpha.com Jul 20, 2022 6:39 pm Patient completes course with Akari's stem cell transplant related complication treatment seekingalpha.com Jul 7, 2022 9:46 pm Akari Therapeutics appoints Melissa Bradford-Klug as COO seekingalpha.com Jun 13, 2022 7:12 pm Akari Therapeutics net loss of $17.4M seekingalpha.com May 16, 2022 6:22 pm Akari Therapeutics slips on $9M equity offering seekingalpha.com Mar 9, 2022 2:12 am Akari Therapeutics picks new CEO seekingalpha.com Mar 2, 2022 8:29 pm Akari advances program for inhaled delivery of nomacopan for lung diseases seekingalpha.com Jan 27, 2022 1:11 am Akari says FDA agrees to use of new manufacturing process for nomacopan for trials seekingalpha.com Jan 20, 2022 3:52 am Akari Therapeutics to raise $6M in ADSs offering seekingalpha.com Dec 31, 2021 2:02 am Akari Therapeutics reports Q3 results seekingalpha.com Dec 3, 2021 8:55 pm Akari nomacopan eyedrops reduced inflammation more than standard of care in model seekingalpha.com Oct 25, 2021 9:16 pm This company doesn't provide a dividend.
Talk about Akari Therapeutics below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
